Ann: Trading Halt, page-50

SPP will be scaled in proportion to your holding ( I presume at record date), which is fair. I too believe it will be heavily scaled back on good results.
Think it will get to at least 14c before the news is out, possibly back to 15c again.

Remember, BIT225 only needs to show efficacy greater than ~65% in genotype 3 patients to show efficacy beyond Interferon/Ribavirin "standard of care". As it has a completely different mechanism of action to Sovaldi and other drugs in development it doesn't have to match their efficacy as it will be used in addition to those drugs in difficult to treat gen 3 patients.. treatment failures and cirrhotic patients. So look for any number above 65%.

Exciting times ahead!